Yeah the so-called "Downrampers" often overlook the deal between CAN and CSIRO, which is to do clinical research, who of course would lead to TGA product approval. Paying in a bit of scrip is fantastic for a business like CAN who is preserving cash.
Ann: Proposed issue of Securities - CAN, page-6
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $17.74M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $3.023K | 78.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 308137 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 166529 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| CAN (ASX) Chart |